Note to our followers: Our nearly 13-year run of daily publication of new content on came to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published contain lessons to help you improve your critical thinking about health care interventions. And those will be still be alive on the site for a couple of years.

Tags: Multiple sclerosis


Reuters story on MS drug for kids even less informative than the FDA news release


HealthDay’s story on stem cells for aggressive MS is upfront about death risk


Potential conflicts of interest abound in HealthDay’s look at Lemtrada for early stages of MS

2 6/13/2016

Thorough and informative: Vox’s story on stem cell therapy for multiple sclerosis


Stem cells for MS: “remarkable” testimonials risk raising false hopes


Nanoparticles Show Potential for Treating MS


New approach could treat MS, other autoimmune diseases

2 7/4/2012

Botox may help multiple sclerosis tremors


Marijuana may ease multiple sclerosis symptoms


New Multiple Sclerosis Therapy Promising in Early Trial